Comparison of 68Ga-DOTATATE Positron Emmited Tomography/Computed Tomography and Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Detection of Liver Metastases from Well-Differentiated Neuroendocrine Tumors
Current Oncology · 2024
DOI: 10.3390/curroncol31010036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2024. Verfasst von Moran Drucker Iarovich und 6 weiteren Autor:innen. Beteiligte Einrichtung: Joint Department of Medical Imaging, University Health Network, Sinai Health Systems, Women's College Hospital, University of Toronto, Toronto, ON M5…. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Liver Neoplasms, Radionuclide Imaging, Gadolinium DTPA. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study aimed to compare the detection of neuroendocrine tumor liver metastases (NLMs) in hepatobiliary-specific contrast-enhanced MRI (pMR) versus 68Ga-DOTATATE PET/CT (DT-PET). This retrospective study cohort included 30 patients with well-differentiated neuroendocrine tumors who underwent both DT-PET and pMR. Two readers independently assessed NLMs count, SUVmax on DT-PET, and signal characteristics on pMR. A consensus review by two additional readers resolved discrepancies between the modalities. Results showed concordance between DT-PET and pMR NLM count in 14/30 patients (47%). pMR identified more NLMs in 12/30 patients (40%), of which 4 patients showed multiple deposits on pMR but only 0–1 lesions on DT-PET. DT-PET detected more in 4/30 patients (13%). Overall, pMR detected more metastases than DT-PET (p = 0.01). Excluding the four outliers, there was excellent agreement between the two methods (ICC: 0.945, 95%CI: 0.930, 0.958). Notably, pMR had a higher NLM detection rate than DT-PET, with correlations found between lesion size on pMR and DT-PET detectability, as well as diffusion restriction on pMR and SUVmax on DT-PET. In conclusion, in consecutive patients with well-differentiated NETs, the detection rate of NLM is higher with pMR than with DT-PET. However, when excluding patients whose tumors do not overexpress somatostatin receptors (13% of the cohort), high concordance in the detection of NLM is observed between DT PET and pMR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joint Department of Medical Imaging, University Health Network, Sinai Health Systems, Women's College Hospital, University of Toronto, Toronto, ON M5R 0A3, Canada.
- Department of Biostatistics, University Health Network, Toronto, ON M5G 2C4, Canada.
ORCID-Profile: Ricarda Hinzpeter, Ur Metser
Zitieren
APA
Drucker Iarovich, M., Hinzpeter, R., Moloney, B. M., Hueniken, K., Veit-Haibach, P., Ortega, C., & Metser, U. (2024). Comparison of 68Ga-DOTATATE Positron Emmited Tomography/Computed Tomography and Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Detection of Liver Metastases from Well-Differentiated Neuroendocrine Tumors. Current Oncology. https://doi.org/10.3390/curroncol31010036
Vancouver
Drucker Iarovich M, Hinzpeter R, Moloney BM, Hueniken K, Veit-Haibach P, Ortega C, et al. Comparison of 68Ga-DOTATATE Positron Emmited Tomography/Computed Tomography and Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Detection of Liver Metastases from Well-Differentiated Neuroendocrine Tumors. Current Oncology. 2024. doi:10.3390/curroncol31010036
BibTeX
@article{DruckerIarovich2024,
author = {Drucker Iarovich, Moran and Hinzpeter, Ricarda and Moloney, Brian Michael and Hueniken, Katrina and Veit-Haibach, Patrick and Ortega, Claudia and Metser, Ur},
title = {Comparison of 68Ga-DOTATATE Positron Emmited Tomography/Computed Tomography and Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Detection of Liver Metastases from Well-Differentiated Neuroendocrine Tumors},
journal = {Current Oncology},
year = {2024},
doi = {10.3390/curroncol31010036}
}
EUVIMED